LOGIN
Single intra-articular injection of hylarunon not effective for treatment of first MTPJ OA
November 2013
Single intra-articular injection of hylarunon not effective for treatment of first MTPJ OA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial
Ann Rheum Dis. 2011 Oct;70(10):1838-41. doi: 10.1136/ard.2011.153049. Epub 2011 Jul 25Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
151 patients with osteoarthritis (OA) of the first metatarsophalangeal joint (MTPJ) were randomized to determine the efficacy of intra-articularly injected hyaluronan for symptomatic treatment of this condition. Patients received a single injection of either Hylan G-F 20 or saline placebo, and were followed for 6 months following the injection. The results indicated that there were no differences ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.